Shopee strengthens fight against counterfeit pharmaceutical products

It has partnered with the Pharmaceutical Security Institute to educate both sellers and shoppers. 

Shopee  has signed an agreement with the Pharmaceutical Security Institute (PSI) to help fight the sale of counterfeit pharmaceutical products. 

Under the Memorandum of Understanding (MoU), Shopee and the PSI will closely partner with sellers and shoppers through educational programmes. 

The industry will also share best practices to raise awareness amongst shoppers. 

“The safety of our shoppers is our priority and we are always looking for ways to enhance our platform and better protect users,” Terence Pang, Chief Operating Officer of Shopee, said.

“This includes partnerships with leading organisations such as the PSI, which allows us to tap on industry knowledge and best practices to strengthen our current measures against counterfeits, and allow users to shop with greater confidence.”

Read more: Shopee owner Sea Ltd is top retailer in Southeast Asia: Euromonitor

According to the PSI, there was a significant increase in the number of counterfeit pharmaceuticals products available to patients as organisations take advantage of easing border restrictions. The rise in consumer demand for telemedicine could also be a factor. 

“It is important for the PSI to work closely with key e-commerce platforms like Shopee to increase public education and awareness on counterfeit medicines to protect consumers,” Todd Ratcliffe, President and CEO of the PSI, said.